234 related articles for article (PubMed ID: 8012687)
41. Comparative renal effects of calcium channel blockers in conscious spontaneously hypertensive rats.
Vemulapalli S; Chiu PJ; Sybertz EJ
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):309-22. PubMed ID: 2888444
[TBL] [Abstract][Full Text] [Related]
42. Calcium ion dependence of myogenic renal plasma flow autoregulation: evidence from the isolated perfused rat kidney.
Cohen AJ; Fray JC
J Physiol; 1982 Sep; 330():449-60. PubMed ID: 7175750
[TBL] [Abstract][Full Text] [Related]
43. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Kanda A; Haruno A; Miyake H; Nagasaka M
J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
[TBL] [Abstract][Full Text] [Related]
44. Autoregulation of zonal glomerular filtration rate and renal blood flow in spontaneously hypertensive rats.
Wang X; Aukland K; Ofstad J; Iversen BM
Am J Physiol; 1995 Oct; 269(4 Pt 2):F515-21. PubMed ID: 7485536
[TBL] [Abstract][Full Text] [Related]
45. Effects of a calcium channel blocker, manidipine hydrochloride, on the regulatory mechanism of glomerular capillary pressure in SHR.
Onuki T
Nihon Jinzo Gakkai Shi; 1995 Feb; 37(2):119-26. PubMed ID: 7752503
[TBL] [Abstract][Full Text] [Related]
46. Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers.
Criscione L; Nellis P; Riniker B; Thomann H; Burdet R
Br J Pharmacol; 1990 May; 100(1):31-6. PubMed ID: 2196966
[TBL] [Abstract][Full Text] [Related]
47. The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats.
Armenia A; Munavvar AS; Abdullah NA; Helmi A; Johns EJ
Br J Pharmacol; 2004 Jun; 142(4):719-26. PubMed ID: 15172958
[TBL] [Abstract][Full Text] [Related]
48. Effects of long-term treatment with the calcium antagonist AE0047 on cerebrovascular autoregulation and hypertrophy in spontaneously hypertensive rats.
Shinyama H; Nagai H; Kawamura T; Narita Y; Nakamura N; Kagitani Y
J Cardiovasc Pharmacol; 1997 Nov; 30(5):616-22. PubMed ID: 9388044
[TBL] [Abstract][Full Text] [Related]
49. [Hypotensive effect of a new calcium antagonist, SR 33557 in conscious rats].
Lacour C; Canals F; Galindo G; Chatelain P; Nisato D
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1281-4. PubMed ID: 2124468
[TBL] [Abstract][Full Text] [Related]
50. Dynamic autoregulation and renal injury in Dahl rats.
Karlsen FM; Andersen CB; Leyssac PP; Holstein-Rathlou NH
Hypertension; 1997 Oct; 30(4):975-83. PubMed ID: 9336403
[TBL] [Abstract][Full Text] [Related]
51. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats.
Garthoff B; Bellemann P
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S36-9. PubMed ID: 2455136
[TBL] [Abstract][Full Text] [Related]
52. Osmotic hypertonicity of the renal medulla during changes in renal perfusion pressure in the rat.
Dobrowolski L; Badzyńska B; Walkowska A; Sadowski J
J Physiol; 1998 May; 508 ( Pt 3)(Pt 3):929-35. PubMed ID: 9518743
[TBL] [Abstract][Full Text] [Related]
53. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
Wang X; Aukland K; Iversen BM
Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
[TBL] [Abstract][Full Text] [Related]
54. Response of the rat mesenteric vasculature to chronic treatment with nitrendipine alone and in combination with atenolol: evidence of a significant drug interaction.
Draper AJ; Kingsbury MP; Redfern PH; Todd MH
J Auton Pharmacol; 1993 Aug; 13(4):281-9. PubMed ID: 8408099
[TBL] [Abstract][Full Text] [Related]
55. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
[TBL] [Abstract][Full Text] [Related]
56. Nitric oxide synthase activity in renal cortex and medulla of normotensive and spontaneously hypertensive rats.
Nava E; Llinás MT; Gonzalez JD; Salazar FJ
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1236-9. PubMed ID: 8972897
[TBL] [Abstract][Full Text] [Related]
57. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
Kazda S; Garthoff B; Knorr A
Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
[TBL] [Abstract][Full Text] [Related]
58. The cardiovascular and renal functional responses to the 5-HT1A receptor agonist flesinoxan in two rat models of hypertension.
Chamienia AL; Johns EJ
Br J Pharmacol; 1996 Aug; 118(8):1891-8. PubMed ID: 8864520
[TBL] [Abstract][Full Text] [Related]
59. Synergism of hydrochlorothiazide and nitrendipine on reduction of blood pressure and blood pressure variability in spontaneously hypertensive rats.
Han P; Chu ZX; Shen FM; Xie HH; Su DF
Acta Pharmacol Sin; 2006 Dec; 27(12):1575-9. PubMed ID: 17112411
[TBL] [Abstract][Full Text] [Related]
60. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
